Polycythemia vera
Disease1 paper
- Humans1
Trial sponsors
Company2 trialsPhase 350 people
1 trialPhase 31,308 people
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
1 trialPhase 2127 people
Ottawa Hospital Research Institute
1 trialPhase 244 people
University of Southern California
1 trialPhase 230 people
University of California-irvine
1 trialPhase 1/227 people
Ohio State University Comprehensive Cancer Center
1 trialPhase 1/212 people
Roswell Park Alliance Foundation, Roswell Park Comprehensive Cancer Center
1 trialPhase 15 people
Latest
1Blood AdvancesHumans
Metformin linked to fewer clots in blood cancer and diabetes
Metformin users had lower blood clot risk than non-users, with a hazard ratio of 0.78, a measure comparing risk over time.Metformin users had lower blood clot risk than non-users, with a hazard ratio of 0.78, a measure comparing risk over time.